125 related articles for article (PubMed ID: 19760369)
1. [Vaccination strategies against HPV. Recommendations from a European perspective].
Deleré Y
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Nov; 52(11):1065-8. PubMed ID: 19760369
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against HPV: indications for women and the impact on the cervical screening programme.
Heideman DA; Snijders PJ; Berkhof J; Verheijen RH; Helmerhorst TJ; Meijer CJ
BJOG; 2008 Jul; 115(8):938-46. PubMed ID: 18651878
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
5. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.
Martínez-Gómez X; Curran A; Campins M; Alemany L; Rodrigo-Pendás JÁ; Borruel N; Castellsagué X; Díaz-de-Heredia C; Moraga-Llop FA; Del Pino M; Torné A
Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782268
[TBL] [Abstract][Full Text] [Related]
7. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
[TBL] [Abstract][Full Text] [Related]
8. European consensus statement on "HPV Vaccination and Colposcopy".
Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
[TBL] [Abstract][Full Text] [Related]
9. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
10. An overview on the implementation of HPV vaccination in Europe.
Bonanni P; Levi M; Latham NB; Bechini A; Tiscione E; Lai P; Panatto D; Gasparini R; Boccalini S
Hum Vaccin; 2011; 7 Suppl():128-35. PubMed ID: 21245659
[TBL] [Abstract][Full Text] [Related]
11. Introduction of human papillomavirus vaccination in Nordic countries.
Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
[TBL] [Abstract][Full Text] [Related]
12. HPV and cervical cancer: screening or vaccination?
Bosch FX; Castellsagué X; de Sanjosé S
Br J Cancer; 2008 Jan; 98(1):15-21. PubMed ID: 18182975
[TBL] [Abstract][Full Text] [Related]
13. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
Delvenne P
Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
[TBL] [Abstract][Full Text] [Related]
14. [Age for HPV vaccination: recommandations from the French high council of public health].
Heard I; Floret D
Med Sci (Paris); 2013 Dec; 29(12):1161-6. PubMed ID: 24356148
[TBL] [Abstract][Full Text] [Related]
15. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
16. Betwixt and Between Well and Sick in Cervical Precancer: Canadian Women's Experiences of Recurring HPV Infections and HPV Vaccination.
Wyndham-West M; Durand N; Santoro A
Can J Nurs Res; 2018 Sep; 50(3):120-132. PubMed ID: 29759001
[TBL] [Abstract][Full Text] [Related]
17. The HPV controversy. Trying to prevent a killer creates concerns.
Stafford EP
Tex Med; 2007 Apr; 103(4):29-33. PubMed ID: 17494247
[No Abstract] [Full Text] [Related]
18. Who should be targeted for vaccination against anal cancer?
Harper DM; Vierthaler SL
Lancet Oncol; 2011 Sep; 12(9):828-9. PubMed ID: 21865086
[No Abstract] [Full Text] [Related]
19. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Arbyn M; Dillner J
J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
[TBL] [Abstract][Full Text] [Related]
20. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]